Editas director receives 51,700 stock options
Editas Medicine director Elliott M. Levy received a grant of stock options covering 51,700 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Editas Medicine director Elliott M. Levy received a grant of stock options covering 51,700 shares of common stock. The options have an exercise price of $2.55 per share and were granted on June 17, 2026. They are scheduled to vest in full on June 17, 2027 and will expire on June 16, 2036 if not exercised. Following this award, Levy holds 51,700 derivative securities directly.
Insider Trade Summary
Grant/Award: 51,700 shares
Grant/Award
1 txn
Insider
Levy Elliott M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 51,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 51,700 contracts (Direct)
Footnotes (1)
- F1. This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.
Key Figures
Options granted: 51,700 shares
Exercise price: $2.55 per share
Expiration date: June 16, 2036
+2 more
5 metrics
Options granted
51,700 shares
Stock option award to director on June 17, 2026
Exercise price
$2.55 per share
Stock option strike price
Expiration date
June 16, 2036
Option term end date
Vesting date
June 17, 2027
Options vest in full on this date
Holdings after grant
51,700 derivative securities
Total options held following transaction
Key Terms
Stock Option (right to buy), derivative security, exercise price, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
derivative security financial
"transaction_type: derivative"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise price financial
"conversion_or_exercise_price: 2.5500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"is scheduled to vest in full on June 17, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-16T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Elliott M. Levy report in this Editas Medicine (EDIT) Form 4?
Elliott M. Levy reported receiving a grant of stock options for 51,700 shares of Editas Medicine common stock. These options were awarded as compensation and are classified as a derivative security with a set exercise price.
What is the exercise price of Elliott Levy’s new Editas Medicine options?
The stock options granted to Elliott M. Levy have an exercise price of $2.55 per share. This means he can buy Editas Medicine common stock at $2.55 once the options vest and before they expire.
When do Elliott Levy’s Editas Medicine options vest and expire?
The options granted to Elliott M. Levy are scheduled to vest in full on June 17, 2027. They will expire on June 16, 2036 if not exercised by that date, according to the disclosed terms.
How many Editas Medicine derivative securities does Elliott Levy hold after this grant?
After this grant, Elliott M. Levy holds 51,700 derivative securities tied to Editas Medicine common stock. This figure reflects his total stock option holdings reported immediately following the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates